Skip to content

Performance and Safety of Use of the KONTACT PERIO LEVEL Transgingival Titanium Dental Implant

Multicenter Observational Study Evaluating the Performance and Safety of Use of the KONTACT PERIO LEVEL Dental Implant in Routine Clinical Practice.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05016401
Acronym
KPL
Enrollment
199
Registered
2021-08-23
Start date
2020-11-06
Completion date
2023-02-02
Last updated
2023-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Partially Edentulous Mandible, Partially Edentulous Maxilla, Tooth Loss

Brief summary

As part of post-marketing clinical follow-up, BIOTECH DENTAL sets up the collection and evaluation of clinical data proactively with the aim of confirming the safety, performance as well as the constantly acceptable nature of the risks identified and of detecting potential emerging risks with the use of Kontact Perio Level implants in everyday practice.

Interventions

DEVICEKONTACT PERIO LEVEL (KPL)

The Kontact™ Perio Level is an implant with a transgingival neck that facilitates one-step surgery.

Sponsors

Biotech Dental
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Edentulous patient requiring the placement of one (or more) dental implant (s) in the maxilla or mandibular * Age ≥ 18 years old * Good general health (ASA score between \[1-2\]) * Sufficient volume and bone quality (with or without bone graft) to support the implant * Non-objection of the patient for the collection of his medical data as part of the study

Exclusion criteria

* Poor oral hygiene * Bruxism, parafunctional habits, occlusion disorders and / or temporomandibular joints * Infections and oral inflammation such as active periodontitis, active gingivitis * Patient with metabolic disorders (eg diabetes mellitus) or bone disease that may compromise peri-implant tissue healing * Heavy smoker (\> 10 cigarettes / day) * Patient with a pathology or immunosuppressive therapy such as chemotherapy, radiotherapy * Patient on prolonged steroid therapy * Titanium / titanium alloy allergy * Alcohol or drug abuse * Pregnant woman (or likely to be pregnant); or breastfeeding * Difficulty of medical follow-up patients with geographical, social or psychological constraints * Persons deprived of liberty or guardianship * Involuntary / patient refusal to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Success rate12 monthsFor an implant to be declared successful it must meet the following criteria as defined by Albrektsson et al. 1986 adapted: Lack of mobility ; Absence of pain ; Lack of radiolucency around the implant ; Absence of bleeding and inflammation ; No significant peri-implant periodontal pocket (≤4mm) ; Stability of the peri-implant bone level over time with marginal bone loss ≤1.5 mm the first year and ≤0.2 mm the following years

Secondary

MeasureTime frameDescription
Prosthetic complications12 monthsAll prosthetic complications having affected the restorations on implants, from the placement of the provisional restorations until the end of the study, are recorded (loosening of the abutment screws, the fracture of the abutment, loss of retention, fracture, etc.)
Primary stabilitysurgical timeValue of the torque during implant placement
Survival rate12 monthsAn implant is classified as surviving if it is still in operation at some point t
Bone Level12 monthsPeri-implant marginal bone loss and / or regrowth is calculated using x-rays
Peri-implantitis12 monthsNumber of peri-implantitis (inflammatory disease causing bone loss around an implant)
Quality of Life12 monthsEvolution of the quality of life score calculated using GOHAI (General Oral Health Assessment Index)
Factors that influence the survival and success rate12 monthsUnivariate statistical analysis of the success and survival rate as a function of: age; sex; bone density; site of implantation; bone graft; type of prosthesis; jaw type;...

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026